[CEO Story]H.C. Wainwright Investment Conference

23 Aug 2021

H.C. Wainwright Investment Conference

CategoryCEO Story

PharmAbcine, a clinical-stage biotech company focusing on the development of next- generation antibody therapeutics, announced today that the Company will participate in H.C. Wainright 23rd Annual Global Investment Conference taking place virtually from September 13-15, 2021.

■ Visit the H.C Wainright website for more details on the event 


■ To request webcasting link for the company’s presentation video, visit the link below


■ The presentation video can be accessed starting from 7:00 AM (Eastern Standard Time) on Monday, September 13, 2021 and will be available for 90 days.)

     2F, Research Building 2, 70,

     Yuseong-daero 1689 beon-gil,
     Yuseong-gu, Daejeon, 34047, Republic of Korea

     HQ +82-42-863-2017 

     R&D Center +82-42-861-2017

     Investor Relations +70-4294-6097 

     FAX +82-42-863-2080 

     COPYRIGHT BY PharmAbcine Inc.